Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Adalimumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Humira 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAAAA
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 40mg/0.8ml solution for injection vials
1001030S0BBACAC
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 80mg/0.8ml solution for injection pre-filled pens
1001030S0BBAHAH
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Humira 80mg/0.8ml solution for injection pre-filled syringes
1001030S0BBAGAG
|
Humira | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.4ml inj pre-filled syringes
1001030S0BEADAE
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.4ml solution for injection pre-filled pens
1001030S0BEACAD
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Hyrimoz 40mg/0.8ml inj pre-filled syringes
1001030S0BEABAA
|
Hyrimoz | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection pre-filled pens
1001030S0BGABAB
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection pre-filled syringes
1001030S0BGACAA
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Idacio 40mg/0.8ml solution for injection vials
1001030S0BGAAAC
|
Idacio | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Imraldi 40mg/0.4ml inj pre-filled syringes
1001030S0BFADAE
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Imraldi 40mg/0.4ml solution for injection pre-filled pens
1001030S0BFACAD
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Imraldi 40mg/0.8ml inj pre-filled syringes
1001030S0BFABAA
|
Imraldi | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 20mg/0.2ml inj pre-filled syringes
1001030S0BHAEAF
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 40mg/0.4ml inj pre-filled syringes
1001030S0BHABAE
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 40mg/0.4ml solution for injection pre-filled pens
1001030S0BHAAAD
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 80mg/0.8ml inj pre-filled syringes
1001030S0BHADAG
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
|
Yuflyma 80mg/0.8ml solution for injection pre-filled pens
1001030S0BHACAH
|
Yuflyma | Adalimumab | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.